RCT of a Weighted Blanket to Reduce Pain in Veterans With Chronic Pain
NCT ID: NCT05963607
Last Updated: 2025-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
160 participants
INTERVENTIONAL
2024-08-01
2029-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functioning Among Veterans
NCT04724694
Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study
NCT02688569
Behavioral Insomnia Therapy in Primary Care
NCT00105872
Developing an Online Therapeutic Intervention for Chronic Pain in Veterans
NCT03655132
SleepSMART for Veterans With MCI and Insomnia
NCT05016960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sensory interventions may offer effective, low-cost complementary tools for chronic pain and sleep disturbance in Veterans. Deep pressure is pleasant and calming25, and reduces acute pain8 and anxiety25 in healthy adults. Weighted Blankets (WB)- blankets sewn with weighted material inside to provide widespread pressure to the body- are a low-cost wellness product used for anxiety and sleep. WBs have demonstrated large reductions in insomnia in individuals with (Cohen's d = 1.9)11 and without12 psychiatric disorders, as well as significant reductions in anxiety and sympathetic arousal26. Tm nl;phe investigators have demonstrated that 1-week of overnight WB use can also reduce chronic pain (severity/interference)27. However, effects and mechanisms of longer WB use have not been examined in individuals with pain and sleep disturbance. The investigators posit that pressure from a WB reduces pain and anxiety while falling asleep and sleeping, decreasing sleep fragmentation and sleep disturbance overnight and, in turn, decreasing pain and pain catastrophizing. The investigators therefore propose a randomized controlled trial examining the effects of WBs on pain and sleep quality in Veterans.
The two objectives of this CSR\&D Merit Review are to determine whether in Veterans with musculoskeletal chronic pain and sleep disturbance, a heavy WB versus light (control) blanket will reduce pain impact (severity/interference) and sleep disturbance, and whether improvements in sleep mediate such reductions in pain. The investigators will recruit Veterans with chronic pain and sleep disturbance from the VA San Diego Healthcare System (VASDHS) and VA San Francisco Healthcare System (VASFHS) and randomize 160 Veterans to receive either a light (3-lb; N = 80) or heavy (15-lb; N = 80) blanket. The investigators will collect measures of pain (primary), pain catastrophizing, and pain medication use, as well as sleep disturbance (primary) and sleep efficiency and total sleep time over 6 weeks of overnight use of the assigned blanket. The investigators will also explore physiological effects of WBs on sleep quality using actigraphy (exploratory) in VASDHS participants. Ecological momentary assessment (EMA) methods will be deployed via smartphone to capture study adherence. Our central hypothesis is that although both study arms will be associated with positive clinical outcomes, deeper pressure from the WB will be associated with significantly greater reductions in pain impact and sleep disturbance, with improvements in sleep mediating reductions in pain. The investigators will examine the following aims:
Aim1: Compare the efficacy of a WB versus control blanket on pain in Veterans with musculoskeletal chronic pain and sleep disturbance. Hypothesis 1a: Pain impact (severity and interference) measured by the Pain, Enjoyment of Life, and General Activity (PEG) Scale28 (primary outcome) and pain catastrophizing (Pain Catastrophizing Scale; PCS)29 will show significantly greater improvement in a group of Veterans with chronic pain over 6 weeks from nightly use of a 15-lb versus 3-lb blanket. Hypothesis 1b: Veterans with chronic pain using the 15-lb versus 3-lb blanket will show significantly greater reductions in pain medication use. Exploratory Hypothesis 1c: Pain impact of 15 vs 3-lb blanket will remain higher 12-weeks after randomization.
Aim2: Compare the efficacy of a WB versus control blanket on sleep disturbance in Veterans with musculoskeletal chronic pain and sleep disturbance. Hypothesis 2a: Veterans using the 15-lb versus 3-lb blanket will show significantly greater improvement in sleep disturbance (Insomnia Severity Index; ISI30; primary outcome measure) and sleep efficiency and total sleep time (Daily Sleep Diary31,32) over 6 weeks of use of a 15-lb versus 3-lb blanket. Exploratory Hypothesis 2b: Veterans using the 15-lb versus 3-lb blanket will show increased sleep efficiency and total sleep time (measured by actigraphy) after six weeks of use.
Aim3: Examine the mediation effect of sleep on pain. Hypothesis 3a: Decreases in sleep disturbance (Insomnia Severity Index; ISI30) will mediate reductions in pain impact (PEG28) over the 6-week intervention. Exploratory Hypothesis 3b: Improvements in sleep efficiency (actigraphy) will mediate reductions in PEG pain.
Our expected outcomes are to identify the effects of a WB on chronic pain and sleep disturbance, and the relationship between these clinical factors. The proposed research findings will have a positive impact by providing evidence for effects on chronic pain and sleep disturbance for this novel, accessible and fully remote intervention. Study results will inform both future research and treatment of chronic pain.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heavy blanket
Wear heavy blanket overnight for 6 weeks
Weighted blanket
A blanket sewn with extra weight in it.
Light blanket
Wear light blanket overnight for 6 weeks
Weighted blanket
A blanket sewn with extra weight in it.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Weighted blanket
A blanket sewn with extra weight in it.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* All genders, ages 18 and older
* chronic non-cancer musculoskeletal pain diagnosis on 2 clinical visits for at least 6 months (ICD codes for chronic pain), and a score of 3 on the numerical pain rating scale from 0-10 over the past week
* sleep disturbance measured by a score \>= 11 on the ISI.
* Serious or untreated mental illness (e.g., psychosis; PTSD will not be excluded),
* other psychosocial instability (e.g., homelessness), or
* suicidal/homicidal ideation/prior attempt within the past 3 years by the Mini-International Neuropsychiatric Interview (MINI)19;
* evidence of opioid use disorder by chart review, or a Current Opioid Misuse Measure (COMM20) score of 9 or both;
* major medical conditions or medical counterindications to use of a 15-lb WB (e.g., self-reported or documented current pregnancy;
* claustrophobia;
* spinal cord injury;
* inability to safely lift 15lb);
* obstructive sleep apnea if untreated, OR STOP-BANG score in "high-risk" category; and
* currently sleeping with a special blanket (such as weighted or cooling blanket).
* Those receiving mental health or other pain treatment will be excluded if there are changes to treatment (either therapy or medications) in the 3 months prior to enrollment or anticipated during the 2-month trial (self-report, confirmed as possible in electronic health record).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Irina Strigo, PhD
Role: PRINCIPAL_INVESTIGATOR
San Francisco VA Medical Center, San Francisco, CA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States
VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States
San Francisco VA Medical Center, San Francisco, CA
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NURP-005-22F
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.